Bank Hapoalim BM Sells 920 Shares of Oracle Corporation $ORCL

Key Points

• Bank Hapoalim BM has reduced its stake in Oracle Corporation by 10.5%, selling 920 shares to hold a total of 7,852 shares valued at approximately $1,717,000.
• Institutional investors own 42.44% of Oracle's stock, with several firms acquiring new stakes or significantly increasing their holdings recently.
• Analysts have set a consensus target price of $304.71 for Oracle shares, with ratings ranging from "Strong Buy" to "Sell" among various analysts, indicating a generally positive outlook.

Bank Hapoalim BM trimmed its holdings in shares of Oracle Corporation (NYSE:ORCL - Free Report) by 10.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,852 shares of the enterprise software provider's stock after selling 920 shares during the period. Bank Hapoalim BM's holdings in Oracle were worth $1,717,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of ORCL. Redmont Wealth Advisors LLC bought a new stake in shares of Oracle during the first quarter worth approximately $27,000. Inlight Wealth Management LLC bought a new stake in shares of Oracle during the first quarter worth approximately $28,000. Iron Horse Wealth Management LLC increased its stake in Oracle by 284.9% in the first quarter. Iron Horse Wealth Management LLC now owns 204 shares of the enterprise software provider's stock valued at $29,000 after purchasing an additional 151 shares in the last quarter. Legend Financial Advisors Inc. bought a new stake in Oracle in the second quarter valued at approximately $34,000. Finally, HighMark Wealth Management LLC bought a new stake in Oracle in the second quarter valued at approximately $38,000. 42.44% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. Redburn Partners set a $175.00 target price on shares of Oracle in a research note on Thursday, September 25th. Citigroup reaffirmed an "outperform" rating on shares of Oracle in a research note on Wednesday, September 10th. Piper Sandler upped their target price on shares of Oracle from $270.00 to $330.00 and gave the company an "overweight" rating in a research note on Wednesday, September 10th. Morgan Stanley upped their target price on shares of Oracle from $246.00 to $320.00 and gave the company an "equal weight" rating in a research note on Tuesday, September 23rd. Finally, DA Davidson upped their target price on shares of Oracle from $220.00 to $300.00 and gave the company a "neutral" rating in a research note on Wednesday, September 10th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-five have assigned a Buy rating, ten have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $304.71.

Insiders Place Their Bets

In related news, insider Michael D. Sicilia sold 33,845 shares of the firm's stock in a transaction on Tuesday, September 23rd. The shares were sold at an average price of $321.16, for a total value of $10,869,660.20. Following the completion of the transaction, the insider owned 132,656 shares of the company's stock, valued at approximately $42,603,800.96. This trade represents a 20.33% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Rona Alison Fairhead bought 480 shares of the firm's stock in a transaction that occurred on Monday, July 7th. The stock was acquired at an average cost of $233.87 per share, with a total value of $112,257.60. Following the transaction, the director owned 22,110 shares of the company's stock, valued at $5,170,865.70. This represents a 2.22% increase in their position. The disclosure for this purchase can be found here. Insiders have sold 104,314 shares of company stock valued at $31,272,223 in the last quarter. Company insiders own 42.20% of the company's stock.

Oracle Stock Down 0.9%

Shares of ORCL stock opened at $286.23 on Friday. The firm has a fifty day moving average of $262.53 and a 200-day moving average of $205.11. The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 3.33. Oracle Corporation has a 12-month low of $118.86 and a 12-month high of $345.72. The company has a market capitalization of $815.99 billion, a price-to-earnings ratio of 66.26, a P/E/G ratio of 3.11 and a beta of 1.53.

Oracle (NYSE:ORCL - Get Free Report) last issued its quarterly earnings data on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.48 by ($0.01). Oracle had a return on equity of 72.93% and a net margin of 21.08%.The company had revenue of $14.93 billion for the quarter, compared to the consensus estimate of $15.04 billion. During the same period in the prior year, the company earned $1.39 EPS. The firm's revenue was up 12.2% on a year-over-year basis. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. As a group, equities research analysts predict that Oracle Corporation will post 5 earnings per share for the current fiscal year.

Oracle Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 23rd. Investors of record on Thursday, October 9th will be given a $0.50 dividend. The ex-dividend date of this dividend is Thursday, October 9th. This represents a $2.00 dividend on an annualized basis and a yield of 0.7%. Oracle's dividend payout ratio (DPR) is 46.30%.

Oracle Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.